Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02316184 · ClinicalTrials.gov registry record · NA
Comparing Brief Alcohol Interventions For HIV-HCV Co-infected Persons
A NA study of HIV and Hepatitis C, sponsored by Butler Hospital.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 2
- Study locations
NCT02316184: Completed NA study of HIV and Hepatitis C, sponsored by Butler Hospital.
NCT02316184 is a NA study of HIV and Hepatitis C that has completed, run by Butler Hospital. The registered enrollment target is 300 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (32% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02316184, a NA study of HIV and Hepatitis C, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
Two types of brief intervention, Brief Advice (BA) and Motivational Interviewing (MI), have been shown to be efficacious in reducing drinking in non-HIV samples. Our goal is to determine whether offering counseling beyond Brief Advice, namely MI, has greater alcohol reduction effects. In the proposed randomized trial, all 300 HIV-HCV co-infected participants will receive BA delivered by their HIV PCP during a regular HIV visit and will then be randomized to either a 30-minute Motivational Interviewing Intervention with a Behavioral Counselor (MI) or to HIV clinic treatment-as-usual. After this initial meeting, drinking "check-in" (MI or BA) sessions will then be provided telephonically every three months for 18 months, with a final assessment at 24 months. Our primary outcome is drinks per week.
Primary Outcome
participants will be asked how many drinks/week they have
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing
- BEHAVIORAL Brief Advice
Study Locations (2)
Rhode Island
- Butler Hospital - Providence
- Miriam Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2015-01 |
| Est. Completion | 2022-02 |
| Phase | NA |
What the finished NCT02316184 record still lists
NCT02316184 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (32% lower).
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Motivational Interviewing is the first listed.
NCT02316184 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT02316184 about?
NCT02316184 is a clinical study titled "Comparing Brief Alcohol Interventions For HIV-HCV Co-infected Persons". Two types of brief intervention, Brief Advice (BA) and Motivational Interviewing (MI), have been shown to be efficacious in reducing drinking in non-HIV samples. Our goal is to determine whether offering counseling beyond Brief Advice, namely MI, has greater alcohol reduction effects. In the propose...
What is the current status of trial NCT02316184?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2015-01. Estimated completion is 2022-02.
What conditions does trial NCT02316184 study?
This clinical trial studies the following conditions: HIV, Hepatitis C.
What interventions are being tested in trial NCT02316184?
The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Brief Advice (BEHAVIORAL).
Who is sponsoring clinical trial NCT02316184?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02316184 being conducted?
This trial has 2 study locations across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02316184's enrollment target sits among peer trials
300 71st of 303 higher than 231 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia